Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15th, 2026.
Covered in this story
What has happened since
- Morgan Stanley is down 14.9% since this was published, 44 days ago.
- Vericel Corp is up 10.0% since this was published, 44 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Morgan Stanley
- Morgan Stanley: $216 → $215 by Jul 2027 via GuruFocus
- RBC Capital Markets: $211 → $243 by Jul 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Morgan Stanley →Dalsna Finance is currently tracking 54 stories mentioning Morgan Stanley, the earliest published 23 Mar 2026.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.